Back
Amicus Therapeutics, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
73
FOLD
Amicus Therapeutics, Inc.
Last Price:
$14.33
Seasonality Move:
-4.88%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing slight buying pressure.
Amicus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.31 | Buy |
| 20-day SMA: | 13.94 | Buy |
| 50-day SMA: | 11.39 | Buy |
| 200-day SMA: | 8.14 | Buy |
| 8-day EMA: | 14.27 | Buy |
| 20-day EMA: | 13.61 | Buy |
| 50-day EMA: | 11.93 | Buy |
| 200-day EMA: | 9.43 | Buy |
Amicus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 86.82 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.55 - 14.91) | Buy |
| Bollinger Bands (100): | (7.54 - 12.04) | Buy |
Amicus Therapeutics, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics, Inc. Stock
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.33 while FOLD 8-day simple moving average is 14.31, which is a Buy signal.
-
The stock price of FOLD is 14.33 while Amicus Therapeutics, Inc. 20-day SMA is 13.94, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day simple moving average is 11.39 while FOLD share price is 14.33, making it a Buy technically.
-
FOLD stock price is 14.33 and Amicus Therapeutics, Inc. 200-day simple moving average is 8.14, creating a Buy signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
73
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. a Buy or a Sell?
-
Amicus Therapeutics, Inc. stock is rated a BuyThe current Amicus Therapeutics, Inc. [FOLD] share price is $14.33. The Score for FOLD is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics, Inc. Stock Info
Market Cap:
4.4B
Price in USD:
14.33
Share Volume:
3.5M
Amicus Therapeutics, Inc. 52-Week Range
52-Week High:
14.38
52-Week Low:
5.51
Buy
73
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Amicus Therapeutics, Inc. Share Price Forecast
-
What is the Amicus Therapeutics, Inc. stock price today?The Amicus Therapeutics, Inc. stock price is 14.33 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics, Inc. is not overvalued.
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.33 while FOLD 8-day exponential moving average is 14.27, which is a Buy signal.
-
The stock price of FOLD is 14.33 while Amicus Therapeutics, Inc. 20-day EMA is 13.61, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day exponential moving average is 11.93 while FOLD share price is 14.33, making it a Buy technically.
-
FOLD stock price is 14.33 and Amicus Therapeutics, Inc. 200-day simple moving average is 9.43, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics, Inc.
Is Amicus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.28 per share.
Technical Analysis of Amicus Therapeutics, Inc.
Should I short Amicus Therapeutics, Inc. stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Amicus Therapeutics, Inc. is a Buy
-
Amicus Therapeutics, Inc. Relative Strength Index (RSI) is 86.82, which suggest Amicus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Amicus Therapeutics, Inc. is (11.55 - 14.91), which suggest Amicus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Amicus Therapeutics, Inc. is (7.54 - 12.04), which suggest Amicus Therapeutics, Inc. is a Buy
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.